MENA pharma market set to top US$ 44 billion
Julphar witnessed strong footfall at the regional debut of the leading global pharmaceutical exhibition, CPhI, in Abu Dhabi, which attracted 250 exhibitors and 4,000 industry professionals.
HE Sheikh Nahyan Bin Mubarak Al Nahyan, the UAE Minister of Tolerance, officially inaugurated the exhibition and was personally escorted to Julphar’s stand by the company’s General Manager, Jerome Carle.
The recently concluded event, at the Abu Dhabi National Exhibition Centre (ADNEC) attracted visitors from across the globe from countries including India, Turkey, Korea, Japan and China.
CPhI is the region’s leading platform bringing together pharma ingredients, product manufacturers, suppliers and buyers covering every step of the pharma supply chain from drug research and discovery to finished dosage.
Regional pharma market healthy
The exhibition is designed to increase partnerships and business opportunities on both a local and international level, which will in turn help to increase the value of the MENA pharma market to more than AED 162 billion (US$ 44 bn) by 2020.
Key topics of discussion at CPhI included the key drivers behind the MEA pharma market, including the growth of the population, greater investment and spending in healthcare from governments, western lifestyle influence on health such as obesity and chronic diseases including diabetes, cardiovascular disease and oncology.
“One of the most eagerly anticipated sessions featured Dr Amin Hussein Amiri, Assistant Undersecretary of Public Health Policy and Licensing, Ministry of Health and Prevention, UAE, in a discussion about the UAE pharmaceutical sector,” noted Cara Turner, Brand Director, CPhI Middle East & Africa.
